Eye implant for treating glaucoma and method for manufacturing same

• US 6,730,056 B1
• Filed: 09/21/2000
• Issued: 05/04/2004
• Est. Priority Date: 09/21/2000
• Status: Expired due to Fees

• Current Assignee: Motorola Solutions, Inc.
• Original Assignee: Motorola, Inc. (Motorola Solutions, Inc.)
• Inventors: Istvan, Rudyard, Ghaem, Sanjar, Turlik, Iwona
• Primary Examiner(s): Sykes, Angela D.
• Assistant Examiner(s): Deak, Leslie R.
• Application Number:
  US09/668,054
• Time in Patent Office: 1,321 Days
• Field of Search: 604/8-10, 606/109
• US Class Current: 604/9
• CPC Class Codes: A61F 9/00781 Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment drainage implants in general A61M27/002

Abstract

An eye implant for treating glaucoma includes a main conduit and a plurality of anchor members formed from a first resilient material. The anchor members are formed such that they are biased to a relaxed condition in a non-aligned position relative to the conduit. To facilitate insertion of the implant into the eye in a minimally invasive surgical procedure, the anchor members are secured together in an aligned condition relative to the conduit with a bonding material. A cutting surface or element is also applied to the anchor members to allow the implant to be inserted directly through the wall of the sclera. The cutting surface is formed of a second material different from the first material. The second material is adapted to dissolve or melt after the implant has been inserted into the eye. Similarly, the bonding material holding the anchor members together in an aligned condition can be made from a dissolveable or heat sensitive material to allow the anchor members to relax to their non-aligned position after insertion into the eye. In the non-aligned position, the anchor members secure the implant to the wall of the sclera. Alternatively, the bonding material holding the anchors together could be made from a material that is ablated away with a laser after the implant has been inserted into the eye.

Claims

1. An eye implant for treating glaucoma, comprising:

a tubular body member forming a conduit having a first end and a second end, said tubular body member defining a longitudinal axis;

a plurality of anchor members, said anchor members integrally formed with said conduit and having a relaxed position in which said anchor members are oriented in a non-aligned condition relative to said tubular body member;

a retaining material coupling the anchor members to the tubular member in an aligned condition;

wherein the retaining material is dissolved or melted while the implant is positioned in the eye to allow the anchor members to move from the aligned condition to the non-aligned condition; and

a cutting edge formed on at least one of said anchor members.

2. The implant of claim 1, wherein said plurality of anchor members comprises two anchors, said anchors and conduit forming a T after said retaining material releases said anchor members.

3. The implant of claim 1, wherein said anchors comprise hallow tubes.

4. The implant of claim 1, wherein said retaining material is made, in whole or in part, from a material selected from the group consisting of Poly Vinyl Alcohol, Poly Vinyl Pyrolidone, and enzymatic activated collagen.

5. The implant of claim 1, wherein said retaining material comprises a material dissolvable by laser obliteration while the implant is positioned in the eye.

6. The implant of claim 1, wherein said tubular conduit further comprises a pressure-controlled valve.

7. The implant of claim 6, wherein said pressure controlled valve comprises a section of said tubular body member, said section connected to said tubular body member by a flexible connecting portion, said section operative to move relative to said axis in response to pressure in said conduit to thereby control the flow of fluid through said conduit.

8. The implant of claim 1, wherein said tubular body member and plurality of anchors are made from a self-forming polymeric material.

9. The implant of claim 1, further comprising a cutting edge formed on at least one of said anchor members, the cutting edge facilitating insertion of said implant into said eye and wherein the cutting edge is formed of material that dissolves or melts while inserted in the eye.

10. The implant of claim 9, wherein the cutting edge comprises a material selected from the group consisting of Poly Vinyl Alcohol, Poly Vinyl Pyrolidone, and enzymatic activated collagen.

19. The implant of claim 1 or claim 11, wherein said anchor members are made from Teflon.

20. The implant of claim 1 or claim 11, wherein said anchor members have an axial length greater than the axial length of said tubular body member.

11. An eye implant for treating glaucoma, comprising:

a tubular body member forming a conduit having a first end and a second end, said tubular body member defining an axis;

a first and second anchor members, said first and second anchor members integrally formed with said conduit and having a first end and a second end, said first end connected to said tubular body member, said first and second anchor members pre-stressed such that said anchor members, in a relaxed condition, are oriented in a non-aligned position relative to said tubular body member;

a bonding material connecting said first and second anchor members together in an aligned relationship with said conduit to facilitate insertion of said implant, wherein said anchor members are released from said bonding material to allow said anchor members to relax and orient themselves in said non-aligned position relative to said tubular body member after said implant has been installed in an eye; and

a cutting element formed on said first and second anchor members, said cutting element formed of a dissolvable of meltable material, said cutting element facilitating insertion of said implant into said eye and dissolving or melting after said implant has been installed in said eye.

12. The implant of claim 11, wherein said first and second anchors comprise hollow tubes.

13. The implant of claim 11, wherein said first and second anchors comprise material which melts or dissolves when said implant is placed within said eye.

14. The implant of claim 11, wherein said bonding material comprises a material dissolvable by laser obliteration while the implant is positioned in the eye.

15. The implant of claim 11, wherein said tubular conduit further comprises a pressure-controlled valve.

16. The implant of claim 15, wherein said pressure controlled valve comprises a section of said tubular body member, said section connected to said tubular body member by a flexible connecting portion, said section operative to move relative to said axis in response to pressure in said conduit to thereby control the flow of fluid through said conduit.

17. The implant of claim 11, wherein said tubular body member and first and second anchors are made from a self-forming polymeric material.

18. The implant of claim 11, wherein the cutting element or the bonding material comprises a material selected from the group consisting of Poly Vinyl Alcohol, Poly Vinyl Pyrolidone, and enzymatic activated collagen.

21. An eye implant for treating glaucoma, comprising:

a tubular body member forming a conduit having a first end and a second end, said tubular body member defining a longitudinal axis;

a plurality of anchor members, said anchor members comprising hollow tubes integrally formed with said conduit and having a relaxed position in which said anchor members are oriented in a non-aligned condition relative to said tubular body member; and

means for retaining the anchor members in a non-aligned condition for placement into the eye and for allowing the anchor members to move to a non-aligned condition while in the eye.

22. The implant of claim 21, further comprising a valve in said tubular body member.

23. The implant of claim 21, further comprising a cutting edge formed on said anchor members made from a material designed to melt or dissolve after said implant has been installed in said eye.

24. The implant of claim 23, wherein the cutting element comprises a material selected from the group consisting of Poly Vinyl Alcohol, Poly Vinyl Pyrolidone, and enzymatic activated collagen.

25. The implant of claim 21, wherein said tubular body member and anchor members are molded into a single piece of compliant, biocompatible material.

26. The implant of claim 21, wherein said plurality of anchor members comprises two anchors, said anchors and conduit forming a T after said retaining means releases said anchor members.

27. The implant of claim 21, wherein said plurality of anchor members comprise at least three anchors.

28. The implant of claim 21, wherein said tubular body member and said plurality of anchors are made from a self-forming polymeric material.